A Look Ahead: Predictions for the Life Sciences in 2026
Written by Tamlyn Oliver for Biocompare
As published in Biocompare
As the life sciences industry looks ahead to 2026, manufacturers are preparing for rapid change driven by technology, sustainability, and evolving production models. In this industry outlook article, life science researchers and experts share predictions on what the coming year may bring, from AI and digital integration to new approaches in bioprocessing.
Greg Walker, Life Science Managing Principal at LCE, discusses how single-use technology, AI, and IoT are reshaping biopharma manufacturing operations.
“In 2026, the factory floor will move closer than ever to becoming fully integrated. The shift away from traditional stainless-steel equipment toward single-use technology (SUT) in bioprocessing, a trend that accelerated in 2025, will become the established norm, especially for smaller-batch, personalized therapies. SUT’s benefits including faster setup, reduced contamination risk, and lower water/chemical consumption align with both the quality and sustainability goals that manufacturers are after. This operational integration will be supported by adoption of AI and IoT sensors, which will provide the real-time visibility needed to manage these flexible systems efficiently and ensure that cost-reduction, quality, and affordability goals are being met. This effort compliments the current trend of utilizing electronic batch record reviews to improve quality while also increasing production efficiencies and reducing time of getting products to our patients.”
Take the Next Step
Let’s drive your success together. Reach out today to see how our expertise can transform your operations.